Sturgeon C, Wagenblast E, Izzo F, Papapetrou E
Blood Cancer Discov. 2024; 6(2):94-109.
PMID: 39652739
PMC: 11876951.
DOI: 10.1158/2643-3230.BCD-24-0235.
Guo X, Atla S, Nyalata S, Alugubelli Y, Chen P, Xu S
J Med Chem. 2024; 67(22):20100-20117.
PMID: 39530508
PMC: 11613437.
DOI: 10.1021/acs.jmedchem.4c01337.
Guo Q, Qiu P, Pan K, Liang H, Liu Z, Lin J
Sci Rep. 2024; 14(1):21449.
PMID: 39271768
PMC: 11399402.
DOI: 10.1038/s41598-024-72406-y.
Filipek-Gorzala J, Kwiecinska P, Szade A, Szade K
Front Oncol. 2024; 14:1308709.
PMID: 38440231
PMC: 10910019.
DOI: 10.3389/fonc.2024.1308709.
Yuan S, Gao M, Wang Y, Lan Y, Li M, Du Y
Cancer Cell Int. 2024; 24(1):66.
PMID: 38336746
PMC: 10858464.
DOI: 10.1186/s12935-024-03265-w.
Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.
Lin T, Jaiswal A, Ritter A, Reppas J, Tran T, Neeb Z
Blood Adv. 2023; 8(2):261-275.
PMID: 38048400
PMC: 10824693.
DOI: 10.1182/bloodadvances.2023011132.
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
Fregona V, Bayet M, Bouttier M, Largeaud L, Hamelle C, Jamrog L
J Exp Med. 2023; 221(1).
PMID: 37930337
PMC: 10626194.
DOI: 10.1084/jem.20230279.
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.
Barbosa K, Deshpande A
Front Oncol. 2023; 13:1204895.
PMID: 37601659
PMC: 10437214.
DOI: 10.3389/fonc.2023.1204895.
Cancers make their own luck: theories of cancer origins.
Jassim A, Rahrmann E, Simons B, Gilbertson R
Nat Rev Cancer. 2023; 23(10):710-724.
PMID: 37488363
DOI: 10.1038/s41568-023-00602-5.
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Pei S, Shelton I, Gillen A, Stevens B, Gasparetto M, Wang Y
Cancer Discov. 2023; 13(9):2032-2049.
PMID: 37358260
PMC: 10527971.
DOI: 10.1158/2159-8290.CD-22-1297.
MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
Komata Y, Kanai A, Maeda T, Inaba T, Yokoyama A
Nat Commun. 2023; 14(1):1979.
PMID: 37031220
PMC: 10082848.
DOI: 10.1038/s41467-023-37712-5.
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.
Anderson N, Sheth V, Li H, Harris M, Qiu S, Crossman D
Leukemia. 2022; 37(3):560-570.
PMID: 36550214
PMC: 10750268.
DOI: 10.1038/s41375-022-01798-5.
Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia.
Matthews A, Pratz K, Carroll M
Cancers (Basel). 2022; 14(23).
PMID: 36497385
PMC: 9735817.
DOI: 10.3390/cancers14235906.
RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4.
Okuda H, Miyamoto R, Takahashi S, Kawamura T, Ichikawa J, Harada I
Nat Commun. 2022; 13(1):6688.
PMID: 36335100
PMC: 9637093.
DOI: 10.1038/s41467-022-34558-1.
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
Chen Y, Li J, Xu L, Gaman M, Zou Z
Cell Death Discov. 2022; 8(1):397.
PMID: 36163119
PMC: 9513079.
DOI: 10.1038/s41420-022-01193-0.
Human acute myeloid leukemia stem cells: evolution of concept.
Shin D
Blood Res. 2022; 57(S1):67-74.
PMID: 35483929
PMC: 9057671.
DOI: 10.5045/br.2022.2021221.
The Opportunity of Proteomics to Advance the Understanding of Intra- and Extracellular Regulation of Malignant Hematopoiesis.
Jassinskaja M, Hansson J
Front Cell Dev Biol. 2022; 10:824098.
PMID: 35350382
PMC: 8957922.
DOI: 10.3389/fcell.2022.824098.
Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors.
Descarpentrie J, Arauzo-Bravo M, He Z, Francois A, Gonzalez A, Garcia-Gallastegi P
Cancers (Basel). 2022; 14(5).
PMID: 35267511
PMC: 8909039.
DOI: 10.3390/cancers14051195.
Human topoisomerases and their roles in genome stability and organization.
Pommier Y, Nussenzweig A, Takeda S, Austin C
Nat Rev Mol Cell Biol. 2022; 23(6):407-427.
PMID: 35228717
PMC: 8883456.
DOI: 10.1038/s41580-022-00452-3.
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation.
Nguyen N, Gudmundsson K, Soltis A, Oakley K, Roy K, Han Y
iScience. 2022; 25(1):103679.
PMID: 35036869
PMC: 8749219.
DOI: 10.1016/j.isci.2021.103679.